BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16234068)

  • 1. Novel therapies for hepatitis C virus based on lessons from virology.
    Glenn JS
    Clin Gastroenterol Hepatol; 2005 Oct; 3(10 Suppl 2):S86-8. PubMed ID: 16234068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular virology of the hepatitis C virus: implication for novel therapies.
    Glenn JS
    Clin Liver Dis; 2005 Aug; 9(3):353-69, v. PubMed ID: 16023970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotypes of hepatitis C virus in relapsed and non-respondent patients and their response to anti-viral therapy in district Mardan, Khyber Pakhtunkhawa, Pakistan.
    Akhtar N; Bilal M; Rizwan M; Khan MA; Khan A
    Asian Pac J Cancer Prev; 2015; 16(3):1037-40. PubMed ID: 25735327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hepatitis C virus life cycle as a target for new antiviral therapies.
    Pawlotsky JM; Chevaliez S; McHutchison JG
    Gastroenterology; 2007 May; 132(5):1979-98. PubMed ID: 17484890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel hepatitis C drugs in current trials.
    Kronenberger B; Welsch C; Forestier N; Zeuzem S
    Clin Liver Dis; 2008 Aug; 12(3):529-55, viii. PubMed ID: 18625427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pipeline for specific subtype amplification and drug resistance detection in hepatitis C virus.
    Soria ME; Gregori J; Chen Q; García-Cehic D; Llorens M; de Ávila AI; Beach NM; Domingo E; Rodríguez-Frías F; Buti M; Esteban R; Esteban JI; Quer J; Perales C
    BMC Infect Dis; 2018 Sep; 18(1):446. PubMed ID: 30176817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus: prospects for future therapies.
    Wilkinson T
    Curr Opin Investig Drugs; 2001 Nov; 2(11):1516-22. PubMed ID: 11763151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New drugs for hepatitis C virus (HCV).
    Clarke BE
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Apr; 14(2):293-305. PubMed ID: 10890323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV genotypes--role in pathogenesis of disease and response to therapy.
    Webster G; Barnes E; Brown D; Dusheiko G
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Apr; 14(2):229-40. PubMed ID: 10890318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus virology and new treatment targets.
    Meier V; Ramadori G
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and evolving therapies for hepatitis C.
    Moradpour D; Blum HE
    Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1199-202. PubMed ID: 10563526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular virology of hepatitis C].
    Moradpour D; Brass V; Gosert R; Wölk B; Blum HE
    Praxis (Bern 1994); 2002 Dec; 91(51-52):2247-53. PubMed ID: 12564041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C: molecular virology and antiviral targets.
    Moradpour D; Brass V; Gosert R; Wölk B; Blum HE
    Trends Mol Med; 2002 Oct; 8(10):476-82. PubMed ID: 12383770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virological tools to diagnose and monitor hepatitis C virus infection.
    Chevaliez S
    Clin Microbiol Infect; 2011 Feb; 17(2):116-21. PubMed ID: 21054664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scotomas in molecular virology and epidemiology of hepatitis C virus.
    Wang Y
    World J Gastroenterol; 2013 Nov; 19(44):7910-21. PubMed ID: 24307785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixing the right hepatitis C inhibitor cocktail.
    Gelman MA; Glenn JS
    Trends Mol Med; 2011 Jan; 17(1):34-46. PubMed ID: 21106440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Antiviral Agents for Treatment of Hepatitis C.
    Egerman RS
    Clin Obstet Gynecol; 2019 Dec; 62(4):823-834. PubMed ID: 31094712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
    Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
    Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a hepatitis C virus (HCV) RNA-positive donor in a treated HCV RNA-negative liver transplant recipient.
    Campos-Varela I; Agudelo EZ; Sarkar M; Roberts JP; Terrault NA
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29125670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C: changing genotype distribution with important implications for patient management.
    van Soest H; Boland GJ; van Erpecum KJ
    Neth J Med; 2006 Apr; 64(4):96-9. PubMed ID: 16609154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.